- Home
- NBTX vs DOYU Comparison
NBTX vs DOYU Comparison
Compare NBTX & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- DOYU
- Stock Information
- Founded
- NBTX 2003
- DOYU 2014
- Country
- NBTX France
- DOYU China
- Employees
- NBTX N/A
- DOYU N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- DOYU Computer Software: Programming Data Processing
- Sector
- NBTX Health Care
- DOYU Technology
- Exchange
- NBTX Nasdaq
- DOYU Nasdaq
- Market Cap
- NBTX 211.9M
- DOYU 195.9M
- IPO Year
- NBTX 2020
- DOYU 2019
- Fundamental
- Price
- NBTX $6.93
- DOYU $8.56
- Analyst Decision
- NBTX Strong Buy
- DOYU Hold
- Analyst Count
- NBTX 1
- DOYU 1
- Target Price
- NBTX $8.00
- DOYU $7.00
- AVG Volume (30 Days)
- NBTX 6.8K
- DOYU 77.4K
- Earning Date
- NBTX 09-17-2025
- DOYU 09-11-2025
- Dividend Yield
- NBTX N/A
- DOYU 230.86%
- EPS Growth
- NBTX N/A
- DOYU N/A
- EPS
- NBTX N/A
- DOYU N/A
- Revenue
- NBTX N/A
- DOYU $575,786,186.00
- Revenue This Year
- NBTX N/A
- DOYU N/A
- Revenue Next Year
- NBTX $221.06
- DOYU N/A
- P/E Ratio
- NBTX N/A
- DOYU N/A
- Revenue Growth
- NBTX N/A
- DOYU N/A
- 52 Week Low
- NBTX $2.76
- DOYU $5.68
- 52 Week High
- NBTX $7.29
- DOYU $20.17
- Technical
- Relative Strength Index (RSI)
- NBTX 71.78
- DOYU 60.42
- Support Level
- NBTX $6.49
- DOYU $8.45
- Resistance Level
- NBTX $7.15
- DOYU $9.34
- Average True Range (ATR)
- NBTX 0.34
- DOYU 0.47
- MACD
- NBTX 0.14
- DOYU 0.03
- Stochastic Oscillator
- NBTX 84.58
- DOYU 60.58
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.